Memphasys has patented the hydrogel membranes used in the Felix™ device in Japan (Patent No. 7058275). The granting of this patent is in addition to the Company’s suite of patents already granted in regions including the USA, China, UK and Australia.
The Felix™ device trademark itself is registered in Australia, US, UK, EU, India, Japan, and Canada. The granting of patents and the registration of trademark in key markets is important for protection of what the Company believes will be a significant device for the IVF industry.
Memphasys Patent Portfolio (April 22) | ||||
Patent title | Country | Status | Expiry Date | Comments |
Cell separation | USA | granted | 14 Jul 26 | NA |
Biocompatible polymeric membranes | USA | granted | 15 Aug 37 | pending in EU |
Sperm separation by electrophoresis | USA | granted | 20 Oct 37 | pending in EU Australia, and Japan |
China | granted | 20 Oct 37 | ||
Electrophoresis device | Australia | pending | - | pending also in USA, China, EU and Japan |
Sperm cell separation by electrophoresis (UoN) | Australia | granted | 7 Oct 24 | exclusively licensed patents from University of Newcastle |
USA | granted | 7 Oct 24 | ||
UK | granted | 7 Oct 24 | ||
Trademarks
The Felix™ device and the Samson™ device product names are protected by trademarks in several major jurisdictions.